RA MEDICAL SYSTEMS INC (RMED) Forecast, Price Target & Analyst Ratings

NYSEARCA:RMED • US74933X3026

Current stock price

0.594 USD
+0.05 (+10%)
At close:
0.5785 USD
-0.02 (-2.61%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RA MEDICAL SYSTEMS INC (RMED).

Forecast Snapshot

Consensus Price Target

Price Target
$7.14
+ 1,102.02% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 13, 2023
Period
Q2 / 2023
EPS Estimate
-$0.31
Revenue Estimate
214.2K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.14
Upside
+ 1,102.02%
From current price of $0.59 to mean target of $7.14, Based on 7 analyst forecasts
Low
$7.07
Median
$7.14
High
$7.35

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for RMED. The average price target is 7.14 USD. This implies a price increase of 1102.02% is expected in the next year compared to the current price of 0.594.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RMED Current Analyst RatingRMED Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

RMED Historical Analyst RatingsRMED Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
RMED was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about RMED.
In the previous month the buy percentage consensus was at a similar level.
RMED was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-10-21HC Wainwright & Co.Initiate Buy
2021-03-17Maxim GroupDowngrade Buy -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 13, 2023
Period
Q2 / 2023
EPS Estimate
-$0.31
Revenue Estimate
214.2K
Revenue Q2Q
4,184.00%
EPS Q2Q
97.72%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

RMED is expected to report earnings on 11/13/2023. The consensus EPS estimate for the next earnings is -0.31 USD and the consensus revenue estimate is 214.20K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
RMED revenue by date.RMED revenue by date.
259K
-79.65%		22K
-91.51%		14K
-36.36%		1.969M
13,964.29%		8.813M
347.59%		21.287M
141.54%
EBITDA
YoY % growth
RMED ebitda by date.RMED ebitda by date.
-33.031M
35.05%		-27.701M
16.14%		-22.368M
19.25%		N/AN/AN/A
EBIT
YoY % growth
RMED ebit by date.RMED ebit by date.
-35.401M
32.71%		-29.266M
17.33%		-22.789M
22.13%		-72.726M
-219.13%		-3.305M
95.46%		4.121M
224.70%
Operating Margin
RMED operating margin by date.RMED operating margin by date.
-13,668.34%-133,027.27%-162,778.57%-3,693.55%-37.50%19.36%
EPS
YoY % growth
RMED eps by date.RMED eps by date.
-1,580.50
70.87%		N/A
87.69%		N/A-12.25-0.32
97.42%		0.30
193.55%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.31
97.72%		-0.23
94.62%		-0.17-0.13
99.46%		-0.12
60.26%		-0.07
69.57%		-0.01
94.12%		0.05
138.46%		0.02
116.67%		0.08
214.29%		0.14
1,500.00%
Revenue
Q2Q % growth		214.2K
4,184.00%		693.6K979.2K1.479M
1,640.00%		1.673M
681.05%		2.429M
250.20%		3.232M
230.07%		4.641M
213.79%		4.264M
154.87%		5.59M
130.14%		6.793M
110.18%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-1.846M
62.57%		-1.652M
61.04%		-1.408M
82.65%		-1.163M
88.82%		-1.193M
35.36%		-795.6K
51.85%		-163.2K
88.41%		724.2K
162.28%		285.6K
123.93%		1.081M
235.87%		2.03M
1,343.87%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RMED Yearly Revenue VS EstimatesRMED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
RMED Yearly EPS VS EstimatesRMED Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2023 2024 2025 0 -2K -4K -6K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.23%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1,049.91%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

RA MEDICAL SYSTEMS INC / RMED Forecast FAQ

What do analysts expect the price target to be for RA MEDICAL SYSTEMS INC (RMED)?

7 analysts have analysed RMED and the average price target is 7.14 USD. This implies a price increase of 1102.02% is expected in the next year compared to the current price of 0.594.

What is the next earnings date for RMED stock?

RA MEDICAL SYSTEMS INC (RMED) will report earnings on 2023-11-13.

What are the consensus estimates for RA MEDICAL SYSTEMS INC (RMED) next earnings?

The consensus EPS estimate for the next earnings of RA MEDICAL SYSTEMS INC (RMED) is -0.31 USD and the consensus revenue estimate is 214.20K USD.

What is the number of analysts for RMED stock?

The number of analysts covering RA MEDICAL SYSTEMS INC (RMED) is 7.